AOD9604 was found to be generally safe with no mutagenic or clastogenic potential
AOD-9604 is a smaller molecule and dissolves faster than Semaglutide or Tirzepatide
During treatment, patients can expect: Gradual dosing when appropriate Weekly self-administered injections Regular progress monitoring Support for side effects such as nausea or digestive changes Lifestyle guidance to support long-term success Ongoing communication with our team Everyone responds differently to medical weight-loss treatment
That is not always obvious at the time, which is why dose and schedule should be set against a confirmed clinical picture rather than guesswork
Megaloblastic anaemia support The condition of megaloblastic anaemia which causes red blood cells to grow in size and develop abnormal shapes responds to treatment with vitamin B12 injections
Transaminases, bilirubin, alkaline phosphatase, albumin, and markers of synthetic function point toward a hepatic cause when they are abnormal